Re: Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

mikesmark

Rank: Vice President [?]

Points: 4516 [?]

Votes: 55 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

in response to

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

mikesmark

posted on Mar 11, 2013 11:03AM

was this included in last years proxy as well or is it knew....thks?

OTHER MATTERS

Neither the Board of Directors nor the management knows of any other business to be presented at the Annual Meeting, but if other matters do properly come before the Annual Meeting, it is intended that the persons named on the proxy card will vote on those matters in accordance with their best judgment.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply